Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
Part of paid clinical trials in Mobile, Alabama.
- Sponsor
- University of Pittsburgh
- Study ID
- NCT06374238
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 16 Years - 30 Years
- Healthy Volunteers
- Not accepted
Interventions
- CBT+ Health coach — BEHAVIORALParticipants will complete the pre-enrollment clinical screening measures (PHQ-9M, GAD-7, and PEG-3) and will repeat those assessments, as well as outcome assessments, at 3 months, 6 months, and 12 months. Participants in CBT w/ Health coach group will engage with the CaRISMA app to complete a daily pain and mood e-diary, daily record of opiate use, and weekly assessment of pain via the Painimation tool. In addition participants will have weekly contact with a peer health coach.
- CBT w/o Health Coach ( self-guided) — BEHAVIORALParticipants will complete the pre-enrollment clinical screening measures (PHQ-9M, GAD-7, and PEG-3) and will repeat those assessments, as well as outcome assessments, at 3 months, 6 months, and 12 months. Participants CBT w/o Health coach groups will engage with the CaRISMA app to complete a daily pain and mood e-diary, daily record of opiate use, and weekly assessment of pain via the Painimation tool.
- Usual Care — BEHAVIORALParticipants will complete the pre-enrollment clinical screening measures (PHQ-9M, GAD-7, and PEG-3) and will repeat those assessments, as well as outcome assessments, at 3 months, 6 months, and 12 months. Participants in the UC group will be asked to engage with the CaRISMA app to complete a daily pain and mood e-diary, daily record of opiate use, and weekly assessment of pain via the Painimation tool. All other care will be at the discretion of their treating provider
Study Details
The study, known as the Peer suppoRt for adolescents and Emerging adults with Sickle cell pain: promoting ENgagement in Cognitive behavioral thErapy (PRESENCE), aims to determine the effectiveness of digital CBT in reducing pain, opioid use, and healthcare utilization among AYAs with SCD. It also seeks to understand the role of personalized peer support in enhancing engagement and outcomes of digital CBT interventions. By leveraging existing infrastructure for delivering virtual peer support interventions, tailored digital CBT programs for individuals with SCD, and partnerships with CBOs, the study aims to provide valuable insights into the feasibility and effectiveness of digital CBT as a pain management strategy for this vulnerable population.
Key Dates
- Start date
- Mar 10, 2025
- Status verified
- Sep 2025
- Primary completion
- Jul 31, 2027
- Completion
- May 31, 2028
Study Design
- Enrollment
- 470 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: CBT w/ Health CoachGroup will utilize the Presence app to undergo self CBT for EMA, but with addition of peer health coaches.
- Active Comparator: CBT w/o Health coach (self-guided)Group will utilize the Presence app to undergo self-guided CBT for EMA, but without peer health coaches.
- Active Comparator: Usual Care with no access to CBTParticipants in the UC group will have access to CaRISMA app to complete a daily pain and mood e-diary, daily record of opiate use, and weekly assessment of pain via the Painimation tool. All other care will be at the discretion of their treating provider
Primary Outcome Measure
Determine the effectiveness of any digital CBT (CBT + peer or self-guided CBT) vs usual care (UC) to improve pain intensity for AYAs with SCD and chronic pain [ Time Frame: Baseline and 6 months ]
Central Contacts
- Steffi Siebert, MPH877-649-0176
Locations (14)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of South Alabama Medical Center | Mobile | Alabama | 36617 | T'Shemika Perryman Antwan Hogue, MD (PRINCIPAL_INVESTIGATOR) Ardie Pack-Mabien, PhD (SUB_INVESTIGATOR) |
| UCLA Mattel Children's Hospital Ronald Reagan Hospital | Los Angeles | California | 90095 | Satiro De Oliveira, MD (PRINCIPAL_INVESTIGATOR) |
| Connecticut Children's Medical Center | Hartford | Connecticut | 06106 | William Zempsky, MD (PRINCIPAL_INVESTIGATOR) |
| Children's Healthcare of Atlanta | Atlanta | Georgia | 30345 | Carlton Dampier, MD (PRINCIPAL_INVESTIGATOR) |
| Ann and Robert H. Lurie Children's Hospital of Chicago | Chicago | Illinois | 60611 | Robert Liem, MD (PRINCIPAL_INVESTIGATOR) |
| The Regents of the University of Michigan | Ann Arbor | Michigan | 48109-1079 | Eric Scott, PhD (PRINCIPAL_INVESTIGATOR) |
| Rutgers New Jersey Medical School | Newark | New Jersey | 07103 | Ashwin Sridharan, MD (PRINCIPAL_INVESTIGATOR) |
| Weil Cornell Medical College | New York | New York | 10065 | Maria DeSancho, MD (PRINCIPAL_INVESTIGATOR) |
| University of Rochester Medical Center | Rochester | New York | 14642 | Suzie Noronha, MD (PRINCIPAL_INVESTIGATOR) |
| Wake Forest Baptist Hospital | Durham | North Carolina | 27106 | Alex George, MD (PRINCIPAL_INVESTIGATOR) |
| East Carolina University Health Medical Center | Greenville | North Carolina | 27834 | Darla Liles, MD (PRINCIPAL_INVESTIGATOR) |
| UPMC Children's Hospital of Pittsburgh | Pittsburgh | Pennsylvania | 15224 | Dr. Cheryl Hillery, MD (PRINCIPAL_INVESTIGATOR) |
| UPMC University of Pittsburgh Classical Hematology Adult Clinic | Pittsburgh | Pennsylvania | 15213 | Laura De Castro, MD (PRINCIPAL_INVESTIGATOR) Ana Radovic, MD (PRINCIPAL_INVESTIGATOR) |
| Virginia Commonwealth University | Richmond | Virginia | 23284 | Wally Smith, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Mobile, AL
Related Studies
- Blood Collection for Research Related to Certain Diseases Involving Blood VesselsEnrolling By Invitation · National Heart, Lung, and Blood Institute (NHLBI) · Bethesda, Maryland
- Study of Panobinostat (LBH589) in Patients With Sickle Cell DiseasePHASE1 · Recruiting · Abdullah Kutlar · Augusta, Georgia
- RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for PainRecruiting · Boston Scientific Corporation · Phoenix, Arizona
- Sickle Cell Clinical Research and Intervention ProgramRecruiting · St. Jude Children's Research Hospital · Peoria, Illinois